#1FUZKK atlas leaders 1–100
Pfizer
New Jersey / New York / Pennsylvania
Diversified pharma
Open article →FUZKK USA TOP 500
USA: Top 500 pharmaceutical, biotechnology and manufacturing companies
The atlas combines innovative pharma, generics, biologics, advanced therapies, radiopharma, diagnostics and CDMOs. Positions 1–100 are FUZKK atlas leaders; positions 101–500 extend coverage across the U.S. manufacturing ecosystem.
500companies
100FUZKK atlas leaders 1–100
400Extended selection 101–500
7hubs
The Top 500 is a FUZKK atlas priority rather than a single official revenue table. Inclusion in an FDA or industry source does not mean product approval, confirmation of a site's current status or actual use of FUZKK.
#2FUZKK atlas leaders 1–100
Johnson & Johnson Innovative Medicine
New Jersey / New York / Pennsylvania
Diversified pharma
Open article →#3FUZKK atlas leaders 1–100
Merck & Co.
New Jersey / New York / Pennsylvania
Diversified pharma
Open article →#4FUZKK atlas leaders 1–100
AbbVie
Midwest / Texas
Diversified pharma
Open article →#5FUZKK atlas leaders 1–100
Bristol Myers Squibb
New Jersey / New York / Pennsylvania
Diversified pharmaOncology / ADC / high-potency
Open article →#6FUZKK atlas leaders 1–100
Eli Lilly and Company
Mid-Atlantic / Southeast
Diversified pharmaPeptides and metabolic medicines
Open article →#7FUZKK atlas leaders 1–100
Amgen
California
Diversified pharmaBiologics
Open article →#8FUZKK atlas leaders 1–100
Gilead Sciences
California
Diversified pharma
Open article →#9FUZKK atlas leaders 1–100
Regeneron Pharmaceuticals
New Jersey / New York / Pennsylvania
Biologics
Open article →#10FUZKK atlas leaders 1–100
Vertex Pharmaceuticals
Massachusetts / New England
Finished dosage forms and small molecules
Open article →#11FUZKK atlas leaders 1–100
Moderna
Massachusetts / New England
Vaccines and plasma products
Open article →#12FUZKK atlas leaders 1–100
Biogen
Massachusetts / New England
Biologics
Open article →#13FUZKK atlas leaders 1–100
Viatris
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#14FUZKK atlas leaders 1–100
Organon
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#15FUZKK atlas leaders 1–100
Zoetis
New Jersey / New York / Pennsylvania
Veterinary pharma
Open article →#16FUZKK atlas leaders 1–100
Incyte
New Jersey / New York / Pennsylvania
BiologicsOncology / ADC / high-potency
Open article →#17FUZKK atlas leaders 1–100
United Therapeutics
New Jersey / New York / Pennsylvania
Biologics
Open article →#18FUZKK atlas leaders 1–100
Alnylam Pharmaceuticals
Massachusetts / New England
RNA and genetic medicines
Open article →#19FUZKK atlas leaders 1–100
Sarepta Therapeutics
Massachusetts / New England
Finished dosage forms and small molecules
Open article →#20FUZKK atlas leaders 1–100
BioMarin Pharmaceutical
California
Biologics
Open article →#21FUZKK atlas leaders 1–100
Jazz Pharmaceuticals
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#22FUZKK atlas leaders 1–100
Ultragenyx Pharmaceutical
Massachusetts / New England
Finished dosage forms and small molecules
Open article →#23FUZKK atlas leaders 1–100
Neurocrine Biosciences
California
Biologics
Open article →#24FUZKK atlas leaders 1–100
Ionis Pharmaceuticals
California
RNA and genetic medicines
Open article →#25FUZKK atlas leaders 1–100
Exelixis
California
Oncology / ADC / high-potency
Open article →#26FUZKK atlas leaders 1–100
Acadia Pharmaceuticals
California
Finished dosage forms and small molecules
Open article →#27FUZKK atlas leaders 1–100
Genentech
California
Biologics
Open article →#28FUZKK atlas leaders 1–100
Thermo Fisher Scientific
Other / National Manufacturing
API / CDMO / manufacturing
Open article →#29FUZKK atlas leaders 1–100
Catalent
Mid-Atlantic / Southeast
API / CDMO / manufacturing
Open article →#30FUZKK atlas leaders 1–100
Charles River Laboratories
Other / National Manufacturing
API / CDMO / manufacturing
Open article →#31FUZKK atlas leaders 1–100
Lonza US
Other / National Manufacturing
API / CDMO / manufacturing
Open article →#32FUZKK atlas leaders 1–100
FUJIFILM Diosynth Biotechnologies
Mid-Atlantic / Southeast
API / CDMO / manufacturing
Open article →#33FUZKK atlas leaders 1–100
Curia Global
Mid-Atlantic / Southeast
API / CDMO / manufacturing
Open article →#34FUZKK atlas leaders 1–100
Cambrex
Mid-Atlantic / Southeast
API / CDMO / manufacturing
Open article →#35FUZKK atlas leaders 1–100
Resilience
Mid-Atlantic / Southeast
API / CDMO / manufacturing
Open article →#36FUZKK atlas leaders 1–100
Emergent BioSolutions
Mid-Atlantic / Southeast
Vaccines and plasma products
Open article →#37FUZKK atlas leaders 1–100
KBI Biopharma
Mid-Atlantic / Southeast
API / CDMO / manufacturingBiologics
Open article →#38FUZKK atlas leaders 1–100
AGC Biologics
Mid-Atlantic / Southeast
API / CDMO / manufacturingBiologics
Open article →#39FUZKK atlas leaders 1–100
Ajinomoto Bio-Pharma Services
Mid-Atlantic / Southeast
API / CDMO / manufacturing
Open article →#40FUZKK atlas leaders 1–100
Alcami
Mid-Atlantic / Southeast
API / CDMO / manufacturing
Open article →#41FUZKK atlas leaders 1–100
Piramal Pharma Solutions
Other / National Manufacturing
API / CDMO / manufacturing
Open article →#42FUZKK atlas leaders 1–100
PCI Pharma Services
Other / National Manufacturing
API / CDMO / manufacturing
Open article →#43FUZKK atlas leaders 1–100
Grand River Aseptic Manufacturing
Mid-Atlantic / Southeast
API / CDMO / manufacturingSterile and injectable products
Open article →#44FUZKK atlas leaders 1–100
Amneal Pharmaceuticals
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#45FUZKK atlas leaders 1–100
ANI Pharmaceuticals
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#46FUZKK atlas leaders 1–100
Amphastar Pharmaceuticals
Midwest / Texas
Sterile and injectable products
Open article →#47FUZKK atlas leaders 1–100
American Regent
New Jersey / New York / Pennsylvania
Vaccines and plasma productsSterile and injectable products
Open article →#48FUZKK atlas leaders 1–100
Hikma Pharmaceuticals USA
New Jersey / New York / Pennsylvania
Finished dosage forms and small moleculesSterile and injectable products
Open article →#49FUZKK atlas leaders 1–100
Teva Pharmaceuticals USA
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#50FUZKK atlas leaders 1–100
Sandoz US
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#51FUZKK atlas leaders 1–100
Sun Pharma USA
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#52FUZKK atlas leaders 1–100
Dr. Reddy's Laboratories USA
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#53FUZKK atlas leaders 1–100
Aurobindo Pharma USA
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#54FUZKK atlas leaders 1–100
Lupin Pharmaceuticals
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#55FUZKK atlas leaders 1–100
Zydus Pharmaceuticals USA
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#56FUZKK atlas leaders 1–100
Torrent Pharma USA
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#57FUZKK atlas leaders 1–100
Apotex Corp.
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#58FUZKK atlas leaders 1–100
Glenmark Pharmaceuticals USA
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#59FUZKK atlas leaders 1–100
Strides Pharma USA
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#60FUZKK atlas leaders 1–100
Meitheal Pharmaceuticals
New Jersey / New York / Pennsylvania
Finished dosage forms and small moleculesSterile and injectable products
Open article →#61FUZKK atlas leaders 1–100
Padagis
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#62FUZKK atlas leaders 1–100
Cipla USA
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#63FUZKK atlas leaders 1–100
Accord Healthcare
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#64FUZKK atlas leaders 1–100
Biocon Biologics USA
New Jersey / New York / Pennsylvania
Finished dosage forms and small moleculesBiologics
Open article →#65FUZKK atlas leaders 1–100
Upsher-Smith Laboratories
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#66FUZKK atlas leaders 1–100
Cosette Pharmaceuticals
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#67FUZKK atlas leaders 1–100
Tris Pharma
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#68FUZKK atlas leaders 1–100
Endo
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#69FUZKK atlas leaders 1–100
AstraZeneca US
Mid-Atlantic / Southeast
Diversified pharma
Open article →#70FUZKK atlas leaders 1–100
GSK US
Mid-Atlantic / Southeast
Diversified pharma
Open article →#71FUZKK atlas leaders 1–100
CSL Seqirus US
Mid-Atlantic / Southeast
Vaccines and plasma products
Open article →#72FUZKK atlas leaders 1–100
Grifols Therapeutics
Mid-Atlantic / Southeast
Vaccines and plasma products
Open article →#73FUZKK atlas leaders 1–100
Bavarian Nordic US
Mid-Atlantic / Southeast
Vaccines and plasma products
Open article →#74FUZKK atlas leaders 1–100
Takeda Pharmaceuticals USA
Massachusetts / New England
Diversified pharma
Open article →#75FUZKK atlas leaders 1–100
Novartis Pharmaceuticals US
New Jersey / New York / Pennsylvania
Diversified pharma
Open article →#76FUZKK atlas leaders 1–100
Sanofi US
New Jersey / New York / Pennsylvania
Diversified pharma
Open article →#77FUZKK atlas leaders 1–100
Boehringer Ingelheim USA
New Jersey / New York / Pennsylvania
Diversified pharma
Open article →#78FUZKK atlas leaders 1–100
Bayer Pharmaceuticals US
New Jersey / New York / Pennsylvania
Diversified pharma
Open article →#79FUZKK atlas leaders 1–100
Novo Nordisk US
New Jersey / New York / Pennsylvania
Peptides and metabolic medicines
Open article →#80FUZKK atlas leaders 1–100
CSL Behring US
New Jersey / New York / Pennsylvania
Vaccines and plasma products
Open article →#81FUZKK atlas leaders 1–100
UCB US
Mid-Atlantic / Southeast
Baseline manufacturing scope
Open article →#82FUZKK atlas leaders 1–100
Lantheus Holdings
Massachusetts / New England
Radiopharmaceuticals
Open article →#83FUZKK atlas leaders 1–100
Foundation Medicine
Massachusetts / New England
BiologicsMolecular diagnostics
Open article →#84FUZKK atlas leaders 1–100
Guardant Health
California
Molecular diagnostics
Open article →#85FUZKK atlas leaders 1–100
Natera
California
Molecular diagnostics
Open article →#86FUZKK atlas leaders 1–100
Illumina
California
Molecular diagnostics
Open article →#87FUZKK atlas leaders 1–100
Myriad Genetics
Pacific Northwest / Mountain
Molecular diagnostics
Open article →#88FUZKK atlas leaders 1–100
Exact Sciences
Midwest / Texas
Molecular diagnostics
Open article →#89FUZKK atlas leaders 1–100
B. Braun Medical USA
Midwest / Texas
Sterile and injectable productsDrug delivery and Medical Devices
Open article →#90FUZKK atlas leaders 1–100
Fresenius Kabi USA
Midwest / Texas
Sterile and injectable products
Open article →#91FUZKK atlas leaders 1–100
BridgeBio Pharma
California
Biologics
Open article →#92FUZKK atlas leaders 1–100
Arrowhead Pharmaceuticals
California
RNA and genetic medicines
Open article →#93FUZKK atlas leaders 1–100
Halozyme Therapeutics
California
Drug delivery and Medical Devices
Open article →#94FUZKK atlas leaders 1–100
CRISPR Therapeutics US
Massachusetts / New England
Cell and gene therapy
Open article →#95FUZKK atlas leaders 1–100
Intellia Therapeutics
Massachusetts / New England
Cell and gene therapy
Open article →#96FUZKK atlas leaders 1–100
Beam Therapeutics
Massachusetts / New England
Cell and gene therapy
Open article →#97FUZKK atlas leaders 1–100
Legend Biotech
New Jersey / New York / Pennsylvania
BiologicsOncology / ADC / high-potency
Open article →#98FUZKK atlas leaders 1–100
PTC Therapeutics
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#99FUZKK atlas leaders 1–100
Rocket Pharmaceuticals
New Jersey / New York / Pennsylvania
Cell and gene therapy
Open article →#100FUZKK atlas leaders 1–100
Roivant Sciences
New Jersey / New York / Pennsylvania
Baseline manufacturing scope
Open article →#101Extended selection 101–500
4D Molecular Therapeutics
California
Cell and gene therapy
Open article →#102Extended selection 101–500
89bio
California
Peptides and metabolic medicines
Open article →#103Extended selection 101–500
Adverum Biotechnologies
California
Cell and gene therapy
Open article →#104Extended selection 101–500
Alector
California
Baseline manufacturing scope
Open article →#105Extended selection 101–500
Allogene Therapeutics
California
Cell and gene therapy
Open article →#106Extended selection 101–500
Alumis
California
Baseline manufacturing scope
Open article →#107Extended selection 101–500
Annexon
California
Baseline manufacturing scope
Open article →#108Extended selection 101–500
Arcellx
California
Cell and gene therapy
Open article →#109Extended selection 101–500
Arcus Biosciences
California
BiologicsOncology / ADC / high-potency
Open article →#110Extended selection 101–500
Arcutis Biotherapeutics
California
Finished dosage forms and small molecules
Open article →#111Extended selection 101–500
ArsenalBio
California
Baseline manufacturing scope
Open article →#112Extended selection 101–500
Assembly Biosciences
California
Biologics
Open article →#113Extended selection 101–500
Atara Biotherapeutics
California
Cell and gene therapy
Open article →#114Extended selection 101–500
Avenzo Therapeutics
California
Oncology / ADC / high-potency
Open article →#115Extended selection 101–500
Avid Bioservices
California
API / CDMO / manufacturing
Open article →#116Extended selection 101–500
Avidity Biosciences
California
BiologicsRNA and genetic medicines
Open article →#117Extended selection 101–500
Belite Bio
California
Baseline manufacturing scope
Open article →#118Extended selection 101–500
BioAge Labs
California
Peptides and metabolic medicines
Open article →#119Extended selection 101–500
BioAtla
California
Baseline manufacturing scope
Open article →#120Extended selection 101–500
Biomea Fusion
California
Baseline manufacturing scope
Open article →#121Extended selection 101–500
Boundless Bio
California
Baseline manufacturing scope
Open article →#122Extended selection 101–500
Calidi Biotherapeutics
California
Finished dosage forms and small molecules
Open article →#123Extended selection 101–500
Capricor Therapeutics
California
Finished dosage forms and small molecules
Open article →#124Extended selection 101–500
CARGO Therapeutics
California
Cell and gene therapy
Open article →#125Extended selection 101–500
Caribou Biosciences
California
BiologicsCell and gene therapy
Open article →#126Extended selection 101–500
Cellares
California
API / CDMO / manufacturingCell and gene therapy
Open article →#127Extended selection 101–500
Cerevance
California
Baseline manufacturing scope
Open article →#128Extended selection 101–500
CG Oncology
California
Oncology / ADC / high-potency
Open article →#129Extended selection 101–500
Cidara Therapeutics
California
Finished dosage forms and small molecules
Open article →#130Extended selection 101–500
Coherus BioSciences
California
Biologics
Open article →#131Extended selection 101–500
Contineum Therapeutics
California
Finished dosage forms and small molecules
Open article →#132Extended selection 101–500
Corcept Therapeutics
California
Finished dosage forms and small molecules
Open article →#133Extended selection 101–500
Crinetics Pharmaceuticals
California
Peptides and metabolic medicines
Open article →#134Extended selection 101–500
Crown Bioscience US
California
API / CDMO / manufacturing
Open article →#135Extended selection 101–500
Cytokinetics
California
Baseline manufacturing scope
Open article →#136Extended selection 101–500
CytomX Therapeutics
California
Finished dosage forms and small molecules
Open article →#137Extended selection 101–500
Denali Therapeutics
California
Finished dosage forms and small molecules
Open article →#138Extended selection 101–500
Eikon Therapeutics
California
Oncology / ADC / high-potency
Open article →#139Extended selection 101–500
Eledon Pharmaceuticals
California
Finished dosage forms and small molecules
Open article →#140Extended selection 101–500
EpiBiologics
California
Biologics
Open article →#141Extended selection 101–500
Erasca
California
Baseline manufacturing scope
Open article →#142Extended selection 101–500
Eureka Therapeutics
California
Oncology / ADC / high-potency
Open article →#143Extended selection 101–500
Fate Therapeutics
California
Cell and gene therapy
Open article →#144Extended selection 101–500
FibroGen
California
Baseline manufacturing scope
Open article →#145Extended selection 101–500
Genesis Therapeutics
California
Finished dosage forms and small molecules
Open article →#146Extended selection 101–500
Heron Therapeutics
California
Finished dosage forms and small molecules
Open article →#147Extended selection 101–500
IDEAYA Biosciences
California
BiologicsOncology / ADC / high-potency
Open article →#148Extended selection 101–500
IGM Biosciences
California
Biologics
Open article →#149Extended selection 101–500
insitro
California
Baseline manufacturing scope
Open article →#150Extended selection 101–500
Janux Therapeutics
California
Oncology / ADC / high-potency
Open article →#151Extended selection 101–500
Kezar Life Sciences
California
Baseline manufacturing scope
Open article →#152Extended selection 101–500
Kodiak Sciences
California
Baseline manufacturing scope
Open article →#153Extended selection 101–500
Kura Oncology
California
Oncology / ADC / high-potency
Open article →#154Extended selection 101–500
Ligand Pharmaceuticals
California
Finished dosage forms and small molecules
Open article →#155Extended selection 101–500
Lyell Immunopharma
California
BiologicsCell and gene therapy
Open article →#156Extended selection 101–500
Maze Therapeutics
California
Finished dosage forms and small molecules
Open article →#157Extended selection 101–500
Nektar Therapeutics
California
Finished dosage forms and small molecules
Open article →#158Extended selection 101–500
Neumora Therapeutics
California
Finished dosage forms and small molecules
Open article →#159Extended selection 101–500
Nkarta
California
Cell and gene therapy
Open article →#160Extended selection 101–500
Nurix Therapeutics
California
Finished dosage forms and small molecules
Open article →#161Extended selection 101–500
Nuvation Bio
California
Baseline manufacturing scope
Open article →#162Extended selection 101–500
Olema Oncology
California
Oncology / ADC / high-potency
Open article →#163Extended selection 101–500
Oncternal Therapeutics
California
Finished dosage forms and small molecules
Open article →#164Extended selection 101–500
Orca Bio
California
Cell and gene therapy
Open article →#165Extended selection 101–500
ORIC Pharmaceuticals
California
Oncology / ADC / high-potency
Open article →#166Extended selection 101–500
Pacira BioSciences
California
Biologics
Open article →#167Extended selection 101–500
Pliant Therapeutics
California
Finished dosage forms and small molecules
Open article →#168Extended selection 101–500
Poseida Therapeutics
California
Cell and gene therapy
Open article →#169Extended selection 101–500
Protagonist Therapeutics
California
Finished dosage forms and small molecules
Open article →#170Extended selection 101–500
Puma Biotechnology
California
Oncology / ADC / high-potency
Open article →#171Extended selection 101–500
Radionetics Oncology
California
Oncology / ADC / high-potency
Open article →#172Extended selection 101–500
RAPT Therapeutics
California
Finished dosage forms and small molecules
Open article →#173Extended selection 101–500
Recludix Pharma
California
Finished dosage forms and small molecules
Open article →#174Extended selection 101–500
ReCode Therapeutics
California
RNA and genetic medicines
Open article →#175Extended selection 101–500
Revolution Medicines
California
Oncology / ADC / high-potency
Open article →#176Extended selection 101–500
Rigel Pharmaceuticals
California
Finished dosage forms and small molecules
Open article →#177Extended selection 101–500
Sana Biotechnology
California
Cell and gene therapy
Open article →#178Extended selection 101–500
Sangamo Therapeutics
California
Cell and gene therapy
Open article →#179Extended selection 101–500
Senti Biosciences
California
BiologicsCell and gene therapy
Open article →#180Extended selection 101–500
Septerna
California
Baseline manufacturing scope
Open article →#181Extended selection 101–500
Shoreline Biosciences
California
BiologicsCell and gene therapy
Open article →#182Extended selection 101–500
SOFIE Biosciences
California
BiologicsRadiopharmaceuticals
Open article →#183Extended selection 101–500
Soleno Therapeutics
California
Finished dosage forms and small molecules
Open article →#184Extended selection 101–500
Spyre Therapeutics
California
Finished dosage forms and small molecules
Open article →#185Extended selection 101–500
Structure Therapeutics
California
Peptides and metabolic medicines
Open article →#186Extended selection 101–500
Sutro Biopharma
California
BiologicsOncology / ADC / high-potency
Open article →#187Extended selection 101–500
Tarsus Pharmaceuticals
California
Finished dosage forms and small molecules
Open article →#188Extended selection 101–500
Tenaya Therapeutics
California
Finished dosage forms and small molecules
Open article →#189Extended selection 101–500
Terns Pharmaceuticals
California
Peptides and metabolic medicines
Open article →#190Extended selection 101–500
Tizona Therapeutics
California
Oncology / ADC / high-potency
Open article →#191Extended selection 101–500
Travere Therapeutics
California
Finished dosage forms and small molecules
Open article →#192Extended selection 101–500
Twist Bioscience
California
Molecular diagnostics
Open article →#193Extended selection 101–500
Vaxcyte
California
Baseline manufacturing scope
Open article →#194Extended selection 101–500
Vera Therapeutics
California
Finished dosage forms and small molecules
Open article →#195Extended selection 101–500
Viking Therapeutics
California
Peptides and metabolic medicines
Open article →#196Extended selection 101–500
Vir Biotechnology
California
Baseline manufacturing scope
Open article →#197Extended selection 101–500
Vistagen Therapeutics
California
Finished dosage forms and small molecules
Open article →#198Extended selection 101–500
Xaira Therapeutics
California
Finished dosage forms and small molecules
Open article →#199Extended selection 101–500
Xencor
California
Biologics
Open article →#200Extended selection 101–500
Zai Lab US
California
Baseline manufacturing scope
Open article →#201Extended selection 101–500
Zymeworks US
California
Biologics
Open article →#202Extended selection 101–500
Abcuro
Massachusetts / New England
Biologics
Open article →#203Extended selection 101–500
Abpro
Massachusetts / New England
Biologics
Open article →#204Extended selection 101–500
Acrivon Therapeutics
Massachusetts / New England
Oncology / ADC / high-potency
Open article →#205Extended selection 101–500
Aerovate Therapeutics
Massachusetts / New England
Finished dosage forms and small molecules
Open article →#206Extended selection 101–500
Affinia Therapeutics
Massachusetts / New England
Cell and gene therapy
Open article →#207Extended selection 101–500
Agios Pharmaceuticals
Massachusetts / New England
Finished dosage forms and small molecules
Open article →#208Extended selection 101–500
Akebia Therapeutics
Massachusetts / New England
Finished dosage forms and small molecules
Open article →#209Extended selection 101–500
Aktis Oncology
Massachusetts / New England
RadiopharmaceuticalsOncology / ADC / high-potency
Open article →#210Extended selection 101–500
Alkeus Pharmaceuticals
Massachusetts / New England
Finished dosage forms and small molecules
Open article →#211Extended selection 101–500
AlloVir
Massachusetts / New England
Baseline manufacturing scope
Open article →#212Extended selection 101–500
Amylyx Pharmaceuticals
Massachusetts / New England
Finished dosage forms and small molecules
Open article →#213Extended selection 101–500
Ankyra Therapeutics
Massachusetts / New England
Oncology / ADC / high-potency
Open article →#214Extended selection 101–500
Anokion
Massachusetts / New England
Baseline manufacturing scope
Open article →#215Extended selection 101–500
Apellis Pharmaceuticals
Massachusetts / New England
Finished dosage forms and small molecules
Open article →#216Extended selection 101–500
Apogee Therapeutics
Massachusetts / New England
Finished dosage forms and small molecules
Open article →#217Extended selection 101–500
Aprea Therapeutics
Massachusetts / New England
Finished dosage forms and small molecules
Open article →#218Extended selection 101–500
Argenx US
Massachusetts / New England
Baseline manufacturing scope
Open article →#219Extended selection 101–500
Artiva Biotherapeutics
Massachusetts / New England
Cell and gene therapy
Open article →#220Extended selection 101–500
Arvinas
Massachusetts / New England
Baseline manufacturing scope
Open article →#221Extended selection 101–500
Astria Therapeutics
Massachusetts / New England
Finished dosage forms and small molecules
Open article →#222Extended selection 101–500
Atea Pharmaceuticals
Massachusetts / New England
Finished dosage forms and small molecules
Open article →#223Extended selection 101–500
Aura Biosciences
Massachusetts / New England
BiologicsOncology / ADC / high-potency
Open article →#224Extended selection 101–500
Bicara Therapeutics
Massachusetts / New England
Biologics
Open article →#225Extended selection 101–500
Bicycle Therapeutics US
Massachusetts / New England
Finished dosage forms and small molecules
Open article →#226Extended selection 101–500
Blueprint Medicines
Massachusetts / New England
Baseline manufacturing scope
Open article →#227Extended selection 101–500
CAMP4 Therapeutics
Massachusetts / New England
RNA and genetic medicines
Open article →#228Extended selection 101–500
CervoMed
Massachusetts / New England
Baseline manufacturing scope
Open article →#229Extended selection 101–500
Clade Therapeutics
Massachusetts / New England
Cell and gene therapy
Open article →#230Extended selection 101–500
Cogent Biosciences
Massachusetts / New England
BiologicsOncology / ADC / high-potency
Open article →#231Extended selection 101–500
Compass Therapeutics
Massachusetts / New England
Oncology / ADC / high-potency
Open article →#232Extended selection 101–500
Convergent Therapeutics
Massachusetts / New England
RadiopharmaceuticalsOncology / ADC / high-potency
Open article →#233Extended selection 101–500
Corbus Pharmaceuticals
Massachusetts / New England
Finished dosage forms and small molecules
Open article →#234Extended selection 101–500
Crossbow Therapeutics
Massachusetts / New England
Biologics
Open article →#235Extended selection 101–500
Cullinan Therapeutics
Massachusetts / New England
Oncology / ADC / high-potency
Open article →#236Extended selection 101–500
Day One Biopharmaceuticals
Massachusetts / New England
BiologicsOncology / ADC / high-potency
Open article →#237Extended selection 101–500
Deciphera Pharmaceuticals
Massachusetts / New England
Finished dosage forms and small molecules
Open article →#238Extended selection 101–500
Disc Medicine
Massachusetts / New England
Baseline manufacturing scope
Open article →#239Extended selection 101–500
Dragonfly Therapeutics
Massachusetts / New England
Oncology / ADC / high-potency
Open article →#240Extended selection 101–500
Dyne Therapeutics
Massachusetts / New England
RNA and genetic medicines
Open article →#241Extended selection 101–500
Editas Medicine
Massachusetts / New England
Cell and gene therapy
Open article →#242Extended selection 101–500
Elektrofi
Massachusetts / New England
Biologics
Open article →#243Extended selection 101–500
Elevation Oncology
Massachusetts / New England
Oncology / ADC / high-potency
Open article →#244Extended selection 101–500
Elicio Therapeutics
Massachusetts / New England
Finished dosage forms and small molecules
Open article →#245Extended selection 101–500
Empress Therapeutics
Massachusetts / New England
Finished dosage forms and small molecules
Open article →#246Extended selection 101–500
Ensoma
Massachusetts / New England
Cell and gene therapy
Open article →#247Extended selection 101–500
Entrada Therapeutics
Massachusetts / New England
RNA and genetic medicines
Open article →#248Extended selection 101–500
Erasca Boston
Massachusetts / New England
Baseline manufacturing scope
Open article →#249Extended selection 101–500
Fulcrum Therapeutics
Massachusetts / New England
Finished dosage forms and small molecules
Open article →#250Extended selection 101–500
Generate Biomedicines
Massachusetts / New England
Biologics
Open article →#251Extended selection 101–500
Generation Bio
Massachusetts / New England
RNA and genetic medicines
Open article →#252Extended selection 101–500
Ginkgo Bioworks
Massachusetts / New England
Baseline manufacturing scope
Open article →#253Extended selection 101–500
Harbour BioMed US
Massachusetts / New England
Biologics
Open article →#254Extended selection 101–500
HiFiBiO Therapeutics
Massachusetts / New England
Biologics
Open article →#255Extended selection 101–500
HotSpot Therapeutics
Massachusetts / New England
Finished dosage forms and small molecules
Open article →#256Extended selection 101–500
Immunitas Therapeutics
Massachusetts / New England
Finished dosage forms and small molecules
Open article →#257Extended selection 101–500
Ipsen Biopharmaceuticals US
Massachusetts / New England
Biologics
Open article →#258Extended selection 101–500
Ironwood Pharmaceuticals
Massachusetts / New England
Finished dosage forms and small molecules
Open article →#259Extended selection 101–500
Jnana Therapeutics
Massachusetts / New England
Finished dosage forms and small molecules
Open article →#260Extended selection 101–500
Kailos Genetics
Massachusetts / New England
Molecular diagnostics
Open article →#261Extended selection 101–500
Karyopharm Therapeutics
Massachusetts / New England
Finished dosage forms and small molecules
Open article →#262Extended selection 101–500
Kelonia Therapeutics
Massachusetts / New England
Cell and gene therapy
Open article →#263Extended selection 101–500
Kiniksa Pharmaceuticals
Massachusetts / New England
Finished dosage forms and small molecules
Open article →#264Extended selection 101–500
Korro Bio
Massachusetts / New England
RNA and genetic medicines
Open article →#265Extended selection 101–500
Kymera Therapeutics
Massachusetts / New England
Finished dosage forms and small molecules
Open article →#266Extended selection 101–500
Marea Therapeutics
Massachusetts / New England
Finished dosage forms and small molecules
Open article →#267Extended selection 101–500
Matchpoint Therapeutics
Massachusetts / New England
Biologics
Open article →#268Extended selection 101–500
Mersana Therapeutics
Massachusetts / New England
Oncology / ADC / high-potency
Open article →#269Extended selection 101–500
MOMA Therapeutics
Massachusetts / New England
Oncology / ADC / high-potency
Open article →#270Extended selection 101–500
Monte Rosa Therapeutics
Massachusetts / New England
Oncology / ADC / high-potency
Open article →#271Extended selection 101–500
Myeloid Therapeutics
Massachusetts / New England
Cell and gene therapy
Open article →#272Extended selection 101–500
Mythic Therapeutics
Massachusetts / New England
Biologics
Open article →#273Extended selection 101–500
Nimbus Therapeutics
Massachusetts / New England
Oncology / ADC / high-potency
Open article →#274Extended selection 101–500
Nuvalent
Massachusetts / New England
Oncology / ADC / high-potency
Open article →#275Extended selection 101–500
Nvelop Therapeutics
Massachusetts / New England
Cell and gene therapy
Open article →#276Extended selection 101–500
Orbital Therapeutics
Massachusetts / New England
RNA and genetic medicines
Open article →#277Extended selection 101–500
Orna Therapeutics
Massachusetts / New England
Cell and gene therapy
Open article →#278Extended selection 101–500
Parabilis Medicines
Massachusetts / New England
Baseline manufacturing scope
Open article →#279Extended selection 101–500
PepGen
Massachusetts / New England
RNA and genetic medicines
Open article →#280Extended selection 101–500
Praxis Precision Medicines
Massachusetts / New England
Baseline manufacturing scope
Open article →#281Extended selection 101–500
Prime Medicine
Massachusetts / New England
Cell and gene therapy
Open article →#282Extended selection 101–500
PureTech Health
Massachusetts / New England
Baseline manufacturing scope
Open article →#283Extended selection 101–500
Ratio Therapeutics
Massachusetts / New England
Radiopharmaceuticals
Open article →#284Extended selection 101–500
Relay Therapeutics
Massachusetts / New England
Oncology / ADC / high-potency
Open article →#285Extended selection 101–500
Remix Therapeutics
Massachusetts / New England
RNA and genetic medicines
Open article →#286Extended selection 101–500
Repare Therapeutics
Massachusetts / New England
Oncology / ADC / high-potency
Open article →#287Extended selection 101–500
Repertoire Immune Medicines
Massachusetts / New England
BiologicsCell and gene therapy
Open article →#288Extended selection 101–500
Scholar Rock
Massachusetts / New England
Baseline manufacturing scope
Open article →#289Extended selection 101–500
Seismic Therapeutic
Massachusetts / New England
Biologics
Open article →#290Extended selection 101–500
Servier Pharmaceuticals
Massachusetts / New England
Finished dosage forms and small molecules
Open article →#291Extended selection 101–500
Sionna Therapeutics
Massachusetts / New England
Finished dosage forms and small molecules
Open article →#292Extended selection 101–500
Stoke Therapeutics
Massachusetts / New England
RNA and genetic medicines
Open article →#293Extended selection 101–500
Tango Therapeutics
Massachusetts / New England
Oncology / ADC / high-potency
Open article →#294Extended selection 101–500
Tectonic Therapeutic
Massachusetts / New England
Biologics
Open article →#295Extended selection 101–500
Theseus Pharmaceuticals
Massachusetts / New England
Finished dosage forms and small molecules
Open article →#296Extended selection 101–500
Third Harmonic Bio
Massachusetts / New England
Baseline manufacturing scope
Open article →#297Extended selection 101–500
TScan Therapeutics
Massachusetts / New England
Cell and gene therapyOncology / ADC / high-potency
Open article →#298Extended selection 101–500
Verve Therapeutics
Massachusetts / New England
Cell and gene therapy
Open article →#299Extended selection 101–500
Vor Bio
Massachusetts / New England
Cell and gene therapy
Open article →#300Extended selection 101–500
Voyager Therapeutics
Massachusetts / New England
Finished dosage forms and small molecules
Open article →#301Extended selection 101–500
Wave Life Sciences
Massachusetts / New England
RNA and genetic medicines
Open article →#302Extended selection 101–500
X4 Pharmaceuticals
Massachusetts / New England
Finished dosage forms and small molecules
Open article →#303Extended selection 101–500
Xilio Therapeutics
Massachusetts / New England
Finished dosage forms and small molecules
Open article →#304Extended selection 101–500
Zenas BioPharma
Massachusetts / New England
Biologics
Open article →#305Extended selection 101–500
Aclaris Therapeutics
Mid-Atlantic / Southeast
Finished dosage forms and small molecules
Open article →#306Extended selection 101–500
Adaptimmune Therapeutics US
Mid-Atlantic / Southeast
Finished dosage forms and small molecules
Open article →#307Extended selection 101–500
Afton Scientific
Mid-Atlantic / Southeast
API / CDMO / manufacturingSterile and injectable products
Open article →#308Extended selection 101–500
Aileron Therapeutics
Mid-Atlantic / Southeast
Finished dosage forms and small molecules
Open article →#309Extended selection 101–500
Aldeyra Therapeutics
Mid-Atlantic / Southeast
Finished dosage forms and small molecules
Open article →#310Extended selection 101–500
Altimmune
Mid-Atlantic / Southeast
Baseline manufacturing scope
Open article →#311Extended selection 101–500
Arcturus Therapeutics
Mid-Atlantic / Southeast
RNA and genetic medicines
Open article →#312Extended selection 101–500
AustinPx
Mid-Atlantic / Southeast
Baseline manufacturing scope
Open article →#313Extended selection 101–500
Avalo Therapeutics
Mid-Atlantic / Southeast
Finished dosage forms and small molecules
Open article →#314Extended selection 101–500
Axogen
Mid-Atlantic / Southeast
Drug delivery and Medical Devices
Open article →#315Extended selection 101–500
Bellicum Pharmaceuticals
Mid-Atlantic / Southeast
Finished dosage forms and small molecules
Open article →#316Extended selection 101–500
BioCryst Pharmaceuticals
Mid-Atlantic / Southeast
Finished dosage forms and small molecules
Open article →#317Extended selection 101–500
Cartesian Therapeutics
Mid-Atlantic / Southeast
Finished dosage forms and small molecules
Open article →#318Extended selection 101–500
Century Therapeutics
Mid-Atlantic / Southeast
Cell and gene therapy
Open article →#319Extended selection 101–500
Chimerix
Mid-Atlantic / Southeast
Baseline manufacturing scope
Open article →#320Extended selection 101–500
Cocrystal Pharma
Mid-Atlantic / Southeast
Finished dosage forms and small molecules
Open article →#321Extended selection 101–500
Context Therapeutics
Mid-Atlantic / Southeast
Finished dosage forms and small molecules
Open article →#322Extended selection 101–500
DPT Laboratories
Mid-Atlantic / Southeast
API / CDMO / manufacturingSterile and injectable products
Open article →#323Extended selection 101–500
Humacyte
Mid-Atlantic / Southeast
Baseline manufacturing scope
Open article →#324Extended selection 101–500
I-Mab US
Mid-Atlantic / Southeast
Baseline manufacturing scope
Open article →#325Extended selection 101–500
Immunocore US
Mid-Atlantic / Southeast
Biologics
Open article →#326Extended selection 101–500
Jubilant Radiopharma
Mid-Atlantic / Southeast
Radiopharmaceuticals
Open article →#327Extended selection 101–500
Larimar Therapeutics
Mid-Atlantic / Southeast
Finished dosage forms and small molecules
Open article →#328Extended selection 101–500
Lexicon Pharmaceuticals
Mid-Atlantic / Southeast
Finished dosage forms and small molecules
Open article →#329Extended selection 101–500
Liquidia
Mid-Atlantic / Southeast
Baseline manufacturing scope
Open article →#330Extended selection 101–500
MacroGenics
Mid-Atlantic / Southeast
Biologics
Open article →#331Extended selection 101–500
MannKind Corporation
Mid-Atlantic / Southeast
Peptides and metabolic medicinesDrug delivery and Medical Devices
Open article →#332Extended selection 101–500
Metrics Contract Services
Mid-Atlantic / Southeast
API / CDMO / manufacturing
Open article →#333Extended selection 101–500
Mineralys Therapeutics
Mid-Atlantic / Southeast
Finished dosage forms and small molecules
Open article →#334Extended selection 101–500
NeuroBo Pharmaceuticals
Mid-Atlantic / Southeast
Finished dosage forms and small molecules
Open article →#335Extended selection 101–500
Novavax
Mid-Atlantic / Southeast
Vaccines and plasma products
Open article →#336Extended selection 101–500
Ocugen
Mid-Atlantic / Southeast
Baseline manufacturing scope
Open article →#337Extended selection 101–500
Orchestra BioMed
Mid-Atlantic / Southeast
Baseline manufacturing scope
Open article →#338Extended selection 101–500
Outlook Therapeutics
Mid-Atlantic / Southeast
Finished dosage forms and small molecules
Open article →#339Extended selection 101–500
Pace Life Sciences
Mid-Atlantic / Southeast
API / CDMO / manufacturing
Open article →#340Extended selection 101–500
Passage Bio
Mid-Atlantic / Southeast
Cell and gene therapy
Open article →#341Extended selection 101–500
Pharmaceutics International
Mid-Atlantic / Southeast
API / CDMO / manufacturing
Open article →#342Extended selection 101–500
Precigen
Mid-Atlantic / Southeast
Baseline manufacturing scope
Open article →#343Extended selection 101–500
Precision BioSciences
Mid-Atlantic / Southeast
BiologicsCell and gene therapy
Open article →#344Extended selection 101–500
Regenxbio
Mid-Atlantic / Southeast
Baseline manufacturing scope
Open article →#345Extended selection 101–500
Societal CDMO
Mid-Atlantic / Southeast
API / CDMO / manufacturing
Open article →#346Extended selection 101–500
Supernus Pharmaceuticals
Mid-Atlantic / Southeast
Finished dosage forms and small molecules
Open article →#347Extended selection 101–500
Taysha Gene Therapies
Mid-Atlantic / Southeast
Cell and gene therapy
Open article →#348Extended selection 101–500
TFF Pharmaceuticals
Mid-Atlantic / Southeast
Finished dosage forms and small molecules
Open article →#349Extended selection 101–500
Trevena
Mid-Atlantic / Southeast
Baseline manufacturing scope
Open article →#350Extended selection 101–500
Vanda Pharmaceuticals
Mid-Atlantic / Southeast
Finished dosage forms and small molecules
Open article →#351Extended selection 101–500
Verismo Therapeutics
Mid-Atlantic / Southeast
Finished dosage forms and small molecules
Open article →#352Extended selection 101–500
Viridian Therapeutics
Mid-Atlantic / Southeast
Finished dosage forms and small molecules
Open article →#353Extended selection 101–500
Abeona Therapeutics Cleveland
Midwest / Texas
Finished dosage forms and small molecules
Open article →#354Extended selection 101–500
Aldevron
Midwest / Texas
API / CDMO / manufacturing
Open article →#355Extended selection 101–500
AmplifyBio
Midwest / Texas
API / CDMO / manufacturing
Open article →#356Extended selection 101–500
Andelyn Biosciences
Midwest / Texas
API / CDMO / manufacturingBiologics
Open article →#357Extended selection 101–500
ANI Pharmaceuticals Minnesota
Midwest / Texas
Finished dosage forms and small molecules
Open article →#358Extended selection 101–500
Assertio
Midwest / Texas
Baseline manufacturing scope
Open article →#359Extended selection 101–500
Battelle Pharma Services
Midwest / Texas
API / CDMO / manufacturing
Open article →#360Extended selection 101–500
Baxter BioPharma Solutions
Midwest / Texas
Biologics
Open article →#361Extended selection 101–500
Castle Biosciences
Midwest / Texas
BiologicsMolecular diagnostics
Open article →#362Extended selection 101–500
Coya Therapeutics
Midwest / Texas
Finished dosage forms and small molecules
Open article →#363Extended selection 101–500
DiaMedica Therapeutics
Midwest / Texas
Finished dosage forms and small molecules
Open article →#364Extended selection 101–500
Eli Lilly Indianapolis
Midwest / Texas
Baseline manufacturing scope
Open article →#365Extended selection 101–500
Eton Pharmaceuticals
Midwest / Texas
Finished dosage forms and small molecules
Open article →#366Extended selection 101–500
Forge Biologics
Midwest / Texas
API / CDMO / manufacturingBiologics
Open article →#367Extended selection 101–500
GlycoMimetics
Midwest / Texas
Baseline manufacturing scope
Open article →#368Extended selection 101–500
Gradalis
Midwest / Texas
Oncology / ADC / high-potency
Open article →#369Extended selection 101–500
Immunome
Midwest / Texas
Biologics
Open article →#370Extended selection 101–500
Kindeva Drug Delivery
Midwest / Texas
Drug delivery and Medical Devices
Open article →#371Extended selection 101–500
Lifecore Biomedical
Midwest / Texas
Drug delivery and Medical Devices
Open article →#372Extended selection 101–500
Lundbeck US
Midwest / Texas
Baseline manufacturing scope
Open article →#373Extended selection 101–500
Mabwell USA
Midwest / Texas
Biologics
Open article →#374Extended selection 101–500
Marker Therapeutics
Midwest / Texas
Oncology / ADC / high-potency
Open article →#375Extended selection 101–500
Moleculin Biotech
Midwest / Texas
Oncology / ADC / high-potency
Open article →#376Extended selection 101–500
Nanoscope Therapeutics
Midwest / Texas
Finished dosage forms and small molecules
Open article →#377Extended selection 101–500
NeuroOne Medical Technologies
Midwest / Texas
Drug delivery and Medical Devices
Open article →#378Extended selection 101–500
NorthStar Medical Radioisotopes
Midwest / Texas
Radiopharmaceuticals
Open article →#379Extended selection 101–500
Nucleus RadioPharma
Midwest / Texas
Radiopharmaceuticals
Open article →#380Extended selection 101–500
Perrigo
Midwest / Texas
Consumer health / OTC
Open article →#381Extended selection 101–500
Plus Therapeutics
Midwest / Texas
Oncology / ADC / high-potency
Open article →#382Extended selection 101–500
Quince Therapeutics
Midwest / Texas
Finished dosage forms and small molecules
Open article →#383Extended selection 101–500
Roche Diagnostics US
Midwest / Texas
Baseline manufacturing scope
Open article →#384Extended selection 101–500
Sarepta Columbus
Midwest / Texas
Baseline manufacturing scope
Open article →#385Extended selection 101–500
Surmodics Pharma
Midwest / Texas
Finished dosage forms and small molecules
Open article →#386Extended selection 101–500
Taro Pharmaceuticals USA
Midwest / Texas
Finished dosage forms and small molecules
Open article →#387Extended selection 101–500
Taysha Gene Therapies Dallas
Midwest / Texas
Baseline manufacturing scope
Open article →#388Extended selection 101–500
Telix Pharmaceuticals US
Midwest / Texas
Radiopharmaceuticals
Open article →#389Extended selection 101–500
Upsher-Smith Minnesota
Midwest / Texas
Baseline manufacturing scope
Open article →#390Extended selection 101–500
Vaxxinity
Midwest / Texas
Baseline manufacturing scope
Open article →#391Extended selection 101–500
XBiotech
Midwest / Texas
Baseline manufacturing scope
Open article →#392Extended selection 101–500
Xeris Biopharma
Midwest / Texas
BiologicsPeptides and metabolic medicines
Open article →#393Extended selection 101–500
Zevra Therapeutics
Midwest / Texas
Finished dosage forms and small molecules
Open article →#394Extended selection 101–500
Ajanta Pharma USA
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#395Extended selection 101–500
Alvogen
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#396Extended selection 101–500
Amring Pharmaceuticals
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#397Extended selection 101–500
Aquestive Therapeutics
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#398Extended selection 101–500
Astellas Pharma US
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#399Extended selection 101–500
AuroMedics Pharma
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#400Extended selection 101–500
Axsome Therapeutics
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#401Extended selection 101–500
BeOne Medicines
New Jersey / New York / Pennsylvania
Biologics
Open article →#402Extended selection 101–500
Camber Pharmaceuticals
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#403Extended selection 101–500
Celularity
New Jersey / New York / Pennsylvania
Baseline manufacturing scope
Open article →#404Extended selection 101–500
Citius Pharmaceuticals
New Jersey / New York / Pennsylvania
Oncology / ADC / high-potency
Open article →#405Extended selection 101–500
Climb Bio
New Jersey / New York / Pennsylvania
Baseline manufacturing scope
Open article →#406Extended selection 101–500
CorMedix
New Jersey / New York / Pennsylvania
Baseline manufacturing scope
Open article →#407Extended selection 101–500
CytoSorbents
New Jersey / New York / Pennsylvania
Baseline manufacturing scope
Open article →#408Extended selection 101–500
Daiichi Sankyo US
New Jersey / New York / Pennsylvania
Baseline manufacturing scope
Open article →#409Extended selection 101–500
Eisai US
New Jersey / New York / Pennsylvania
Baseline manufacturing scope
Open article →#410Extended selection 101–500
Ferring Pharmaceuticals US
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#411Extended selection 101–500
Fortress Biotech
New Jersey / New York / Pennsylvania
Baseline manufacturing scope
Open article →#412Extended selection 101–500
Granules Pharmaceuticals
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#413Extended selection 101–500
Harmony Biosciences
New Jersey / New York / Pennsylvania
Biologics
Open article →#414Extended selection 101–500
Helsinn Therapeutics US
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#415Extended selection 101–500
Hetero USA
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#416Extended selection 101–500
Immunic
New Jersey / New York / Pennsylvania
Baseline manufacturing scope
Open article →#417Extended selection 101–500
Ingenus Pharmaceuticals
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#418Extended selection 101–500
Interpace Biosciences
New Jersey / New York / Pennsylvania
BiologicsMolecular diagnostics
Open article →#419Extended selection 101–500
Kallyope
New Jersey / New York / Pennsylvania
Baseline manufacturing scope
Open article →#420Extended selection 101–500
Kyowa Kirin US
New Jersey / New York / Pennsylvania
Baseline manufacturing scope
Open article →#421Extended selection 101–500
Lannett
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#422Extended selection 101–500
LEO Pharma US
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#423Extended selection 101–500
Lisata Therapeutics
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#424Extended selection 101–500
Macleods Pharma USA
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#425Extended selection 101–500
Madrigal Pharmaceuticals
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#426Extended selection 101–500
Matinas BioPharma
New Jersey / New York / Pennsylvania
Biologics
Open article →#427Extended selection 101–500
MSN Pharmaceuticals USA
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#428Extended selection 101–500
Mustang Bio
New Jersey / New York / Pennsylvania
Baseline manufacturing scope
Open article →#429Extended selection 101–500
Nuvectis Pharma
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#430Extended selection 101–500
Optinose
New Jersey / New York / Pennsylvania
Baseline manufacturing scope
Open article →#431Extended selection 101–500
Otsuka America Pharmaceutical
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#432Extended selection 101–500
PAI Pharma
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#433Extended selection 101–500
Palatin Technologies
New Jersey / New York / Pennsylvania
Baseline manufacturing scope
Open article →#434Extended selection 101–500
Palisade Bio
New Jersey / New York / Pennsylvania
Baseline manufacturing scope
Open article →#435Extended selection 101–500
PDS Biotechnology
New Jersey / New York / Pennsylvania
Oncology / ADC / high-potency
Open article →#436Extended selection 101–500
Phathom Pharmaceuticals
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#437Extended selection 101–500
Phio Pharmaceuticals
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#438Extended selection 101–500
Purdue Pharma
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#439Extended selection 101–500
Rhodes Pharmaceuticals
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#440Extended selection 101–500
Rising Pharma Holdings
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#441Extended selection 101–500
Royalty Pharma
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#442Extended selection 101–500
Schrödinger
New Jersey / New York / Pennsylvania
Baseline manufacturing scope
Open article →#443Extended selection 101–500
Somerset Therapeutics
New Jersey / New York / Pennsylvania
Finished dosage forms and small moleculesSterile and injectable products
Open article →#444Extended selection 101–500
Taiho Oncology
New Jersey / New York / Pennsylvania
Oncology / ADC / high-potency
Open article →#445Extended selection 101–500
TG Therapeutics
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#446Extended selection 101–500
Tonix Pharmaceuticals
New Jersey / New York / Pennsylvania
Finished dosage forms and small molecules
Open article →#447Extended selection 101–500
Tourmaline Bio
New Jersey / New York / Pennsylvania
Oncology / ADC / high-potency
Open article →#448Extended selection 101–500
Traws Pharma
New Jersey / New York / Pennsylvania
Oncology / ADC / high-potency
Open article →#449Extended selection 101–500
Treeline Biosciences
New Jersey / New York / Pennsylvania
BiologicsOncology / ADC / high-potency
Open article →#450Extended selection 101–500
Volastra Therapeutics
New Jersey / New York / Pennsylvania
Oncology / ADC / high-potency
Open article →#451Extended selection 101–500
XGen Pharmaceuticals
New Jersey / New York / Pennsylvania
Finished dosage forms and small moleculesSterile and injectable products
Open article →#452Extended selection 101–500
Y-mAbs Therapeutics
New Jersey / New York / Pennsylvania
Oncology / ADC / high-potency
Open article →#453Extended selection 101–500
Abzena US
Other / National Manufacturing
API / CDMO / manufacturing
Open article →#454Extended selection 101–500
Adare Pharma Solutions
Other / National Manufacturing
API / CDMO / manufacturing
Open article →#455Extended selection 101–500
Alcami Corporation
Other / National Manufacturing
API / CDMO / manufacturing
Open article →#456Extended selection 101–500
Berkshire Sterile Manufacturing
Other / National Manufacturing
API / CDMO / manufacturingSterile and injectable products
Open article →#457Extended selection 101–500
CordenPharma US
Other / National Manufacturing
API / CDMO / manufacturing
Open article →#458Extended selection 101–500
CoreRx
Other / National Manufacturing
API / CDMO / manufacturing
Open article →#459Extended selection 101–500
Evonik Health Care US
Other / National Manufacturing
API / CDMO / manufacturing
Open article →#460Extended selection 101–500
Hovione US
Other / National Manufacturing
API / CDMO / manufacturing
Open article →#461Extended selection 101–500
Jubilant HollisterStier
Other / National Manufacturing
Sterile and injectable products
Open article →#462Extended selection 101–500
LGM Pharma
Other / National Manufacturing
API / CDMO / manufacturing
Open article →#463Extended selection 101–500
Matica Biotechnology
Other / National Manufacturing
API / CDMO / manufacturing
Open article →#464Extended selection 101–500
MilliporeSigma BioReliance
Other / National Manufacturing
API / CDMO / manufacturing
Open article →#465Extended selection 101–500
Noramco
Other / National Manufacturing
API / CDMO / manufacturing
Open article →#466Extended selection 101–500
Pfanstiehl
Other / National Manufacturing
API / CDMO / manufacturing
Open article →#467Extended selection 101–500
Ropack Pharma Solutions US
Other / National Manufacturing
API / CDMO / manufacturing
Open article →#468Extended selection 101–500
Samsung Biologics America
Other / National Manufacturing
API / CDMO / manufacturingBiologics
Open article →#469Extended selection 101–500
Seqens North America
Other / National Manufacturing
API / CDMO / manufacturing
Open article →#470Extended selection 101–500
Sharp Services
Other / National Manufacturing
API / CDMO / manufacturing
Open article →#471Extended selection 101–500
SK pharmteco US
Other / National Manufacturing
API / CDMO / manufacturing
Open article →#472Extended selection 101–500
Sterling Pharma Solutions US
Other / National Manufacturing
API / CDMO / manufacturing
Open article →#473Extended selection 101–500
Therapure US
Other / National Manufacturing
Baseline manufacturing scope
Open article →#474Extended selection 101–500
UPM Pharmaceuticals
Other / National Manufacturing
API / CDMO / manufacturing
Open article →#475Extended selection 101–500
Vetter Development Services USA
Other / National Manufacturing
API / CDMO / manufacturing
Open article →#476Extended selection 101–500
Wacker Biotech US
Other / National Manufacturing
API / CDMO / manufacturing
Open article →#477Extended selection 101–500
WuXi Advanced Therapies US
Other / National Manufacturing
API / CDMO / manufacturing
Open article →#478Extended selection 101–500
Absci
Pacific Northwest / Mountain
Baseline manufacturing scope
Open article →#479Extended selection 101–500
Achieve Life Sciences
Pacific Northwest / Mountain
Baseline manufacturing scope
Open article →#480Extended selection 101–500
Adaptive Biotechnologies
Pacific Northwest / Mountain
Baseline manufacturing scope
Open article →#481Extended selection 101–500
AGC Biologics Seattle
Pacific Northwest / Mountain
API / CDMO / manufacturingBiologics
Open article →#482Extended selection 101–500
AltPep
Pacific Northwest / Mountain
Baseline manufacturing scope
Open article →#483Extended selection 101–500
Aptevo Therapeutics
Pacific Northwest / Mountain
Finished dosage forms and small molecules
Open article →#484Extended selection 101–500
Athira Pharma
Pacific Northwest / Mountain
Finished dosage forms and small molecules
Open article →#485Extended selection 101–500
Clene Nanomedicine
Pacific Northwest / Mountain
Baseline manufacturing scope
Open article →#486Extended selection 101–500
Cocrystal Pharma Seattle
Pacific Northwest / Mountain
Finished dosage forms and small molecules
Open article →#487Extended selection 101–500
CordenPharma Colorado
Pacific Northwest / Mountain
Finished dosage forms and small molecules
Open article →#488Extended selection 101–500
Corvus Pharmaceuticals
Pacific Northwest / Mountain
Finished dosage forms and small molecules
Open article →#489Extended selection 101–500
Just-Evotec Biologics
Pacific Northwest / Mountain
API / CDMO / manufacturingBiologics
Open article →#490Extended selection 101–500
Kriya Therapeutics
Pacific Northwest / Mountain
Cell and gene therapy
Open article →#491Extended selection 101–500
Lineage Cell Therapeutics
Pacific Northwest / Mountain
Cell and gene therapy
Open article →#492Extended selection 101–500
Lumen Bioscience
Pacific Northwest / Mountain
Baseline manufacturing scope
Open article →#493Extended selection 101–500
Lyell Seattle
Pacific Northwest / Mountain
Baseline manufacturing scope
Open article →#494Extended selection 101–500
Omeros
Pacific Northwest / Mountain
Baseline manufacturing scope
Open article →#495Extended selection 101–500
Perspective Therapeutics
Pacific Northwest / Mountain
Radiopharmaceuticals
Open article →#496Extended selection 101–500
Recursion Pharmaceuticals
Pacific Northwest / Mountain
Finished dosage forms and small molecules
Open article →#497Extended selection 101–500
Sana Biotechnology Seattle
Pacific Northwest / Mountain
Baseline manufacturing scope
Open article →#498Extended selection 101–500
Sera Prognostics
Pacific Northwest / Mountain
Molecular diagnostics
Open article →#499Extended selection 101–500
Tolmar
Pacific Northwest / Mountain
Baseline manufacturing scope
Open article →#500Extended selection 101–500
TwinStrand Biosciences
Pacific Northwest / Mountain
Biologics
Open article →—